XXXX : associated arthroscopic findings and results after repair.

@entity1 @entity75 @entity5040 @entity924 @entity603 @entity130
PURPOSE: The purpose of this study was to identify the intra-articular pathology associated with peroneal @entity924 and report the outcomes after tendon repair or tenodesis with arthroscopic treatment. METHODS: Thirty @entity1 were evaluated who underwent ankle arthroscopy followed by peroneal tendon repair. Intra-articular pathology was treated arthroscopically before peroneal tendon surgery was performed. All @entity1 were available for a minimum 2-year follow-up. Preoperative and postoperative American Orthopaedic Foot _ Ankle Society and Karlsson scores were analyzed for all @entity1 . RESULTS: A total of 60 @entity75 were treated arthroscopically in 30 ankles. We diagnosed 13 lesions preoperatively (22%), and 47 lesions (78%) were discovered during arthroscopy. Of the @entity1 , 5 (17%) had associated anterolateral instability requiring an open reconstruction. Soft-tissue impingement was seen in 6 @entity1 (20%), anterior @entity5040 in 4 (13%), loose bodies in 4 (13%), @entity75 in 4 (13%), extensive scar tissue in 24 (80%), extensive @entity603 in 7 (23%), @entity130 in 2 (7%), and a torn posterior transverse tibiofibular ligament in 2 (5%). Postoperative American Orthopaedic Foot _ Ankle Society and Karlsson scores were significantly improved compared with preoperative scores. @entity1 with chronic complaints before surgery had better outcome scores than @entity1 with an isolated, acute twisting injury. It is unclear whether the incidental pathology discovered at the time of arthroscopic examination influenced outcome measures. CONCLUSIONS: All @entity1 with peroneal @entity924 had associated intra-articular pathology, with the majority of @entity1 having more than 1 intra-articular lesion. For @entity1 meeting surgical criteria, correction of the @entity924 and arthroscopic treatment of the @entity75 produced statistically significantly improved results and @entity1 satisfaction, paralleling historical controls. LEVEL OF EVIDENCE: Level IV, therapeutic case series.
